Skip to main content
Equibles

FMS · Fresenius Medical Care AG · Metrics

Track FMS — free

Use FMS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FMS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$21.56 +0.15 (+0.70%) At close · Oct 21
Rebalance outlook locked
Market Cap
$11.47B
Shares
532.22M
Volume · Oct 21 1.26M Avg daily vol (3M) 896.19K

FMS metrics

71 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$21.56
Market cap
$11.47B

Price action

20 metrics
Price change (1W)
+0.1%
Price change (30D)
-4.2%
Price change (3M)
-11.3%
Price change (6M)
-5.7%
Price change (YTD)
-9.5%
Price change (1Y)
-20.5%
Trailing year
Price change (5Y)
-40.2%
52-week high
$27.37
52-week low
$20.19
Change from 52-week high
-21.2%
Change from 52-week low
+6.8%
Annualized volatility
30.4%
Annualized volatility (3M)
26.7%
Beta
0.2
RSI (14D)
44.2
Price vs SMA 50
-4.3%
Price vs SMA 200
-5.8%
Avg volume (3M)
896,186
Relative volume
1.4
Average dollar volume
$20.34M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
532.22M

Valuation

12 metrics
P / E (TTM)
10.5
Trailing earnings · reciprocal yield 9.5%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 197.5%
P / book
0.8
reciprocal yield 124.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
3.5
reciprocal yield 28.8%
Earnings yield
9.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
4.0%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.87
Dividend growth YoY
+7.0%
Dividend growth streak
2
Last ex-dividend
2026-05-22

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
9.4%
Trailing 12 months
Net margin
4.8%
Gross profit (TTM)
—
Operating profit (TTM)
$1.82B
Net income (TTM)
$1.09B
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
20.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+1.4%
Year over year
Net income growth YoY
-3.1%
Revenue (TTM)
$22.66B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.4%
Year over year · more shares
Revenue CAGR (3Y)
+0.4%
Revenue CAGR (5Y)
+1.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+3.2%

Quality

14 metrics
Return on equity
7.5%
Return on assets
3.0%
Debt / equity
—
Current ratio
1.1
EBITDA (TTM)
$3.79B
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
4.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.21B
Total assets
$35.73B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$3.30B
Capital expenditures (TTM)
—
R&D (TTM)
$180.01M
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
0.8%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
236
13F filer change QoQ
+15
Institutional ownership
8.0%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-4.7%
Holder tenure
17.3
Price vs estimated holder cost
-9.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.5%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1333141 CUSIP 358029106 13F (30d) 45 filings 44 filers Visit website Investor relations